Ascendis Pharma A/S (asnd 2.25 04/01/28)
13F holders, Q3 2025 (September 30)4holders +1
1new positions
0sold out
$9.74avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Ascendis Pharma A/S (asnd 2.25 04/01/28) in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were Lombard Odier Asset Management (Europe) Ltd ($46.5M), State of Wisconsin Investment Board ($4.1M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.8M).
- Company
- Ascendis Pharma A/S (asnd 2.25 04/01/28)
- CUSIP
- 04351PAD3
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $46.5M |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 1,211,600 shares bought, net +1,211,600 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Lombard Odier Asset Management (Europe) Ltd | 3.43% | New | 211,600 | $46.5M |
| State of Wisconsin Investment Board | 0.01% | Add +50.0% | 3,000,000 | $4.1M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,000,000 | $2.8M |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $398K |
"% of holder's portfolio" is ASCENDIS PHARMA A/S (ASND 2.25 04/01/28)'s weight in each manager's 13F, not the share of Ascendis Pharma A/S (asnd 2.25 04/01/28) the manager owns.